Inflammatory Skin Disease with Skin Necrosis in Dogs (Superficial Necrolytic Dermatitis, SND)
- Occurrence: very rare
- Location of disease: Skin/Fur
When to visit the vet?
Non-urgent see a veterinarian within 2–3 days
If the condition worsens / symptoms persist, consult a veterinarian.
Definition
Superficial necrolytic dermatitis (SND), also known as “Hepatocutaneous Syndrome” or “metabolic epidermal necrosis,” is a rare skin disease in dogs characterized by degenerative changes in the skin surface and systemic metabolic disorders.
The most important facts at a glance
Superficial necrolytic dermatitis (SND) is a complex skin disease in dogs often associated with systemic diseases such as liver disease, diabetes mellitus, or pancreatic Tumors. The disease is characterized by Skin lesions, Crusts, and pad fissures, and can also lead to severe Pain. The exact causes are not fully understood, but it is suspected that impaired amino acid and protein synthesis plays a major role. A liver anomaly can lead to a deficiency of essential amino acids, which impairs the structural integrity of the skin. Oxidative stress and inflammatory processes could also contribute to its development.
The diagnosis is based on clinical symptoms, skin biopsies, and tests to identify underlying diseases. Blood tests and imaging procedures are important for detecting any anomaly. Treatment requires a holistic approach that addresses both Skin changes and systemic diseases. A high-protein diet, medications to support liver function, and amino acid supplementation where necessary can help. If needed, surgical interventions or targeted therapies may be required.
The prognosis depends on the underlying cause, and early diagnosis as well as comprehensive treatment are crucial. Prevention measures focus on the early detection and treatment of liver problems and other systemic diseases. Research is investigating the biochemical mechanisms of the disease as well as possible genetic predispositions to develop targeted therapeutic approaches.
Causes
SND is a complex disease often associated with systemic health problems, particularly liver disease, diabetes mellitus, or pancreatic Tumors. The exact pathophysiology of the disease is not fully understood, but it is believed to be related to impaired amino acid and protein synthesis, which leads to Skin changes. These metabolic disorders impair skin integrity and lead to the formation of Skin lesions.
A key aspect of the development of SND is the role of the liver. Liver abnormalities are found in many affected dogs, which can lead to inadequate production and metabolism of proteins and amino acids. This is believed to lead to a deficiency of essential amino acids in the skin, which impairs the structural integrity of the skin and leads to the characteristic Lesions.
Furthermore, there is evidence that oxidative stress and Inflammatory conditions can also contribute to the pathological changes observed in SND. In some cases, a genetic predisposition may also play a role, with certain dog breeds being more commonly affected than others.
Symptoms
The symptoms of SND are mainly dermatological and include characteristic Skin changes that mostly occur on the paws, the rhinarium, and the ears. The skin often shows thickening, redness, Scaling, and Crusts. The Lesions are frequently distributed symmetrically.
In addition to the Skin changes, dogs with SND may also show systemic symptoms such as Lethargy, loss of appetite, and Weight loss. In advanced cases, severe liver dysfunction can occur, which may cause additional systemic signs.
In some cases, nail changes can also be observed, such as brittleness or deformation of the claws. These symptoms can be painful for the dog and impair its quality of life.
Therapy
The treatment of SND requires a holistic approach that addresses both the Skin changes and the underlying systemic diseases. Dietary therapy with a high-protein, balanced diet can help improve skin health and alleviate symptoms.
Medications that support liver function, such as ursodeoxycholic acid or other hepatoprotective agents, may also be part of the treatment plan. In some cases, the administration of amino acids or zinc supplements may be indicated to correct deficiencies and promote skin healing.
In advanced cases or in the presence of Tumors, surgical intervention or targeted therapy may be required. Continuous monitoring and adjustment of treatment are crucial to control the course of the disease and improve the quality of life of the affected dog.
Prognosis and follow-up care
The prognosis for dogs with SND is variable and depends heavily on the underlying cause and the course of the disease. In cases where the underlying disease can be treated or controlled, the dog’s condition may improve and quality of life can be maintained.
However, SND is often associated with chronic and serious systemic diseases, which makes the overall prognosis cautious. Early diagnosis and a comprehensive treatment approach are crucial to achieving the best possible results.
Regular follow-up and monitoring of health status are important to detect complications and adjust therapy as needed.
Prevention
Since SND is often associated with systemic diseases such as liver problems or diabetes mellitus, the prevention of underlying diseases is an important aspect. Regular health check-ups, including blood tests and liver function tests, can help detect and treat any anomaly early before SND develops.
A balanced diet and a healthy lifestyle are also important for promoting the dog’s general health and reducing the risk of metabolic disorders. In dogs with a genetic predisposition, increased vigilance is required to recognize early signs of the disease and act quickly.
Although there is no specific preventive measure that can completely prevent SND, careful health monitoring and proactive care can reduce the risk of complications and improve the dog’s quality of life.
Outlook on current research
Superficial necrolytic dermatitis (SND), also known as superficial degenerative Skin inflammation, is a rare but complex skin disease in dogs primarily characterized by a combination of Skin lesions and systemic disorders. Research on SND focuses on understanding the underlying causes, improving diagnosis methods, and developing more effective treatment strategies. A major focus is on investigating the links between SND and liver disease, as most affected dogs also exhibit liver problems. Scientists are studying the biochemical mechanisms that lead to Skin changes to develop targeted therapeutic approaches.
New studies are exploring the role of amino acids and their deficiency, as a striking feature of SND is a lack of amino acids in the skin. Researchers are trying to determine whether the supplementation of certain amino acids has a therapeutic effect. In parallel, the influence of nutritional factors is being examined to see if a special diet can alleviate the symptoms of the disease.
Another area of research is the genetic predisposition for SND. Scientists are analyzing genetic patterns in affected dog breeds to identify possible genetic markers that indicate a susceptibility to the disease. In the future, this could lead to preventive measures to identify and protect at-risk dogs early on.
In diagnostics, emphasis is placed on the development of non-invasive techniques. Current research is investigating the use of advanced imaging procedures and blood tests to detect the disease early and differentiate it from other skin diseases. The goal is to shorten the time to diagnosis and improve treatment planning.
Clinical trials are testing the effectiveness of various medications for alleviating symptoms. In addition to conventional treatments such as corticosteroids and antibiotics, new drugs are being tested that specifically address the biochemical changes in the skin. Furthermore, the effect of phototherapy as a supplementary treatment method is being investigated.
Research on SND is progressing continuously and offers hope for improved diagnosis and treatment options. These developments could not only improve the well-being of affected dogs but also provide valuable insights into related skin diseases in other species.
Frequently Asked Questions (FAQs)
1. What are the main symptoms of SND in dogs?
2. Which dogs are most commonly affected by SND?
3. How is SND diagnosed?
4. Can SND be cured?
5. What treatment options are available for dogs with SND?
6. What role does diet play in the treatment of SND?
7. Are there preventive measures against SND?
8. How does SND affect a dog's life in the long term?
9. How important is an early diagnosis of SND?
10. Is SND in dogs contagious to other animals or humans?
Literature
- Loftus, J. P., Center, S. A., Astor, M., Miller, A. J., & Peters-Kennedy, J. (2022). Clinical features and amino acid profiles of dogs with hepatocutaneous syndrome or hepatocutaneous-associated hepatopathy. Journal of Veterinary Internal Medicine, 36(1), 97–105. https://doi.org/10.1111/jvim.16259
- Loftus, J. P., Center, S. A., Miller, A. J., Peters-Kennedy, J., & Astor, M. (2022). Treatment and outcomes of dogs with hepatocutaneous syndrome or hepatocutaneous-associated hepatopathy. Journal of Veterinary Internal Medicine, 36(1), 106–112. https://doi.org/10.1111/jvim.16323
- Jaffey, J. A., Backus, R. C., Sprinkle, M., Ruggiero, C., Ferguson, S. H., & Shumway, K. (2020). Successful long-term management of canine superficial necrolytic dermatitis with amino acid infusions and nutritionally balanced home-made diet modification. Frontiers in Veterinary Science, 7, 28. https://doi.org/10.3389/fvets.2020.00028
- Outerbridge, C. A., Marks, S. L., & Rogers, Q. R. (2002). Plasma amino acid concentrations in 36 dogs with histologically confirmed superficial necrolytic dermatitis. Veterinary Dermatology, 13(4), 177–186. https://doi.org/10.1046/j.1365-3164.2002.00295.x
- Gross, T. L., Song, M. D., Havel, P. J., & Ihrke, P. J. (1993). Superficial necrolytic dermatitis (necrolytic migratory erythema) in dogs. Veterinary Pathology, 30(1), 75–81. https://doi.org/10.1177/030098589303000110
- Nyland, T. G., Barthez, P. Y., Ortega, T. M., & Davis, C. R. (1996). Hepatic ultrasonographic and pathologic findings in dogs with canine superficial necrolytic dermatitis. Veterinary Radiology & Ultrasound, 37(3), 200–205. https://doi.org/10.1111/j.1740-8261.1996.tb01221.x
- Oberkirchner, U., Linder, K. E., Zadrozny, L., & Olivry, T. (2010). Successful treatment of canine necrolytic migratory erythema (superficial necrolytic dermatitis) due to metastatic glucagonoma with octreotide. Veterinary Dermatology, 21(5), 510–516. https://doi.org/10.1111/j.1365-3164.2009.00876.x